Avadel Pharmaceuticals plc
AVDL
$14.20
$0.201.43%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 81.55M | 66.48M | 73.78M | 65.81M | 71.38M |
| Total Receivables | 40.63M | 41.58M | 34.10M | 37.10M | 34.30M |
| Inventory | 23.48M | 20.41M | 20.30M | 16.10M | 13.31M |
| Prepaid Expenses | 12.67M | 9.96M | 5.15M | 6.31M | 6.11M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 773.00K | 825.00K | 882.00K | 1.95M | 672.00K |
| Total Current Assets | 159.11M | 139.26M | 134.21M | 127.26M | 125.78M |
|
|
|||||
| Total Current Assets | 159.11M | 139.26M | 134.21M | 127.26M | 125.78M |
| Net Property, Plant & Equipment | 11.01M | 11.67M | 12.86M | 13.76M | 14.51M |
| Long-term Investments | 16.84M | 16.84M | 16.84M | 16.84M | 16.84M |
| Goodwill | 16.84M | 16.84M | 16.84M | 16.84M | 16.84M |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 208.00K | 190.00K | 337.00K | 399.00K | 391.00K |
| Total Assets | 187.16M | 167.95M | 164.24M | 158.25M | 157.52M |
|
|
|||||
| Total Accounts Payable | 10.11M | 9.12M | 7.33M | 7.92M | 9.79M |
| Total Accrued Expenses | 28.25M | 23.97M | 24.54M | 20.43M | 21.00M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 723.00K | 2.68M | 2.47M | 2.60M | 2.42M |
| Total Finance Division Other Current Liabilities | 17.98M | 15.17M | 14.49M | 11.83M | 11.39M |
| Total Other Current Liabilities | 17.98M | 15.17M | 14.49M | 11.83M | 11.39M |
| Total Current Liabilities | 57.07M | 50.93M | 48.83M | 42.78M | 44.61M |
|
|
|||||
| Total Current Liabilities | 57.07M | 50.93M | 48.83M | 42.78M | 44.61M |
| Long-Term Debt | 35.32M | 35.52M | 35.25M | 34.44M | 35.49M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.00M | 2.19M | 1.12M | 1.22M | 1.31M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.06M | 5.24M | 5.18M | 5.15M | 5.82M |
| Total Liabilities | 96.45M | 93.88M | 90.39M | 83.59M | 87.23M |
|
|
|||||
| Common Stock & APIC | 903.94M | 897.63M | 892.76M | 887.75M | 881.16M |
| Retained Earnings | -789.58M | -799.25M | -794.33M | -789.29M | -786.66M |
| Treasury Stock & Other | -23.65M | -24.31M | -24.58M | -23.80M | -24.22M |
| Total Common Equity | 90.71M | 74.07M | 73.85M | 74.66M | 70.29M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 90.71M | 74.07M | 73.85M | 74.66M | 70.29M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 90.71M | 74.07M | 73.85M | 74.66M | 70.29M |
|
|
|||||